One Infusion, Zero Tumor: How Engineered T-Cells Conquered a Teen's Recurrent Cancer

A 17-year-old German cyclist who'd battled kidney cancer since age 7 received one infusion of engineered T-cells last year — and has been cancer-free for over a year. Published Aug. 12 in the New England Journal of Medicine, the case marks a rare win for personalized cell therapy against a solid tumor, a category that has stubbornly resisted the immune-boosting approaches that revolutionized blood cancer treatment. Dr....